This is a selection of Dr. Schlappack’s papers

Homeopathy. 2004 Oct;93(4):210-5.

Homeopathic treatment of radiation-induced itching in breast cancer patients. A prospective observational study. Schlappack O.

Acta Med Austriaca. 2001;28(5):135-40.

Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer–a retrospective analysis. Baur M, Schlappack O, Havelec L, Wrba F, Dittrich C.

3rd Medical Department with Oncology, Kaiser Franz Josef Hospital, Kundratstrasse 3, A-1100 Vienna.

Int J Cancer. 1999 Nov 12;83(4):526-31.

Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin. C. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Glossl J, Mach L. Zentrum für Angewandte Genetik, Universität für Bodenkultur, Vienna, Austria.

Cancer Chemother Pharmacol. 1995;37(1-2):91-6.

Pharmacokinetics of 4′-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer. Mader RM, Zilg H, Schlappack O, Steger GG, Baur M, Greifenberg B, Heberle U, Dittrich C. Department of Internal Medicine I, University of Vienna, Austria.

Strahlenther Onkol. 1994 Jan;170(1):25-9.

A critical consideration of the combined radiochemotherapy of head and neck tumors.
Schlappack O, Springer B, Hainz A. Universitätsklinik für Strahlentherapie und Strahlenbiologie, Wien.

Wien Klin Wochenschr. 1992;104(23):714-6

Differential prognosis of patients with breast cancer with pleuritis carcinomatosa and with pulmonary lymphangiosis carcinomatosa. Baur M, Schlappack O, Jakesz R, Dittrich C.
Abteilung für Onkologie, Universitätsklinik fur Innere Medizin I, Wien.

Br J Cancer. 1991 Oct;64(4):663-70.

Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. Schlappack OK, Zimmermann A, Hill RP.
Ontario Cancer Institute, University of Toronto, Canada.

Wien Klin Wochenschr. 1991;103(11):332-9.

5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma. Baur M, Schlappack O, Havelec L, Mader R, Marosi C, Scheithauer W, Dittrich C. Universitätsklinik für Chemotherapie, Wien.

Eur J Cancer. 1991;27(3):254-6.

Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses. Steger GG, Wrba F, Mader R, Schlappack O, Dittrich C, Rainer H. Department of Chemotherapy, University of Vienna, Austria.

Am J Clin Oncol. 1990;13 Suppl 1:S29-39.

Phase I-II study on weekly administration of pirarubicin in patients with metastatic breast cancer.
Dittrich C, Baur M, Mader R, Schlappack O, Dudczak R, Leitha T, Lenzhofer R, Hoffmann S, Vieder L, Heberle U. Department of Chemotherapy, University of Vienna, Austria.

Eur J Cancer Clin Oncol. 1988 Apr;24(4):777-81.

Growth and chemotherapy of a human germ-cell tumour line (GCT 27). Schlappack OK, Bush C, Delic JI, Steel GG. Radiotherapy Research Unit, Institute of Cancer Research, Sutton, Surrey, U.K.